Orchestra BioMed Ownership | Who Owns Orchestra BioMed?


OverviewForecastRevenueFinancialsChart

Orchestra BioMed Ownership Summary


Orchestra BioMed is owned by 5.09% institutional investors, 15.32% insiders, and 79.59% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 21.63% of OBIO shares.

OBIO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOrchestra BioMed5.09%15.32%79.59%
SectorHealthcare Stocks 42.64%10.86%46.50%
IndustryBiotech Stocks 45.45%10.77%43.78%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp8.31M21.63%$20.60M
Perceptive advisors5.29M13.79%$13.13M
Vanguard group1.60M4.18%$6.66M
Alyeska investment group1.37M3.56%$3.39M
Affinity asset advisors727.27K1.89%$1.80M
Blackrock funding, inc. /de630.90K1.64%$2.62M
Geode capital management473.36K1.23%$1.97M
Knoll capital management455.13K1.19%$421.16K
Price t rowe associates inc /md/421.61K1.10%$1.05M
Dafna capital management363.64K0.95%$901.82K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lasry marc60.87K1.00%$150.96K
Amh equity166.00K0.51%$411.68K
Knott david m jr250.00K0.48%$1.04M
Perceptive advisors5.29M0.38%$13.13M
Rtw investments, lp8.31M0.25%$20.60M
Knoll capital management455.13K0.23%$421.16K
Dafna capital management363.64K0.22%$901.82K
Affinity asset advisors727.27K0.16%$1.80M
Holos integrated wealth51.59K0.12%$222.37K
Able financial group13.40K0.01%$55.62K

Top Buyers

HolderShares% AssetsChange
Alyeska investment group1.37M0.01%1.37M
Affinity asset advisors727.27K0.16%727.27K
Perceptive advisors5.29M0.38%700.00K
Dafna capital management363.64K0.22%363.64K
Amh equity166.00K0.51%166.00K

Top Sellers

HolderShares% AssetsChange
Pathstone---1.01M
Renaissance151.30K0.00%-229.21K
Bank of new york mellon---52.49K
Marshall wace, llp---49.47K
Td asset management45.69K0.00%-46.99K

New Positions

HolderShares% AssetsChangeValue
Alyeska investment group1.37M0.01%1.37M$3.39M
Affinity asset advisors727.27K0.16%727.27K$1.80M
Dafna capital management363.64K0.22%363.64K$901.82K
Amh equity166.00K0.51%166.00K$411.68K
Cresset asset management30.00K0.00%30.00K$74.40K

Sold Out

HolderChange
Eversource wealth advisors-1.00
True wealth design-6.00
Gamma investing-101.00
Sierra ocean-119.00
Russell investments group-193.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202510-82.76%1,953,498-89.23%50.23%4-88.57%3-81.25%
Jun 30, 2025585.45%18,134,637-4.51%471.91%3552.17%16-11.11%
Mar 31, 2025548.00%18,940,1491.07%492.00%22-31.25%18157.14%
Dec 31, 20245210.64%19,199,4870.91%512.00%3425.93%7-22.22%
Sep 30, 2024472.17%19,025,94933.83%503.21%27-10.00%928.57%

Recent Insider Transactions


DateNameRoleActivityValue
Nov 14, 2025Hochman David P See RemarksBuy$20.35K
Sep 19, 2025Aryeh Jason-Buy$2.45K
Aug 25, 2025Fain Eric S-Buy$15.03K
Aug 25, 2025Sherman Darren See RemarksBuy$7.86K
Aug 21, 2025Hochman David P See RemarksBuy$14.94K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q41-
2025 Q39-
2025 Q221
2025 Q1--

OBIO Ownership FAQ


Who Owns Orchestra BioMed?

Orchestra BioMed shareholders are primarily institutional investors at 5.09%, followed by 15.32% insiders and 79.59% retail investors. The average institutional ownership in Orchestra BioMed's industry, Biotech Stocks , is 45.45%, which Orchestra BioMed falls below.

Who owns the most shares of Orchestra BioMed?

Orchestra BioMed’s largest shareholders are Rtw investments, lp (8.31M shares, 21.63%), Perceptive advisors (5.29M shares, 13.79%), and Vanguard group (1.6M shares, 4.18%). Together, they hold 39.60% of Orchestra BioMed’s total shares outstanding.

Does Blackrock own Orchestra BioMed?

BlackRock is not among the top 10 institutional shareholders of Orchestra BioMed.

Who is Orchestra BioMed’s biggest shareholder by percentage of total assets invested?

Lasry marc is Orchestra BioMed’s biggest shareholder by percentage of total assets invested, with 1.00% of its assets in 60.87K Orchestra BioMed shares, valued at 150.96K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools